All charts and data below are with dividends reinvested. (Inflation adjustment is OFF !)
| Mon 2012-12-10? to Mon 2025-05-12? | ||||||
|---|---|---|---|---|---|---|
| ABBV × | ||||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10? to Mon 2025-05-12? |
Overall
Return |
Exponential
Trendline |
||||
|---|---|---|---|---|---|---|
| ABBV × |
+798.40%
+19.34%/yr |
+17.54%/yr
(R2=0.953) |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Mon 2012-12-10? to Mon 2025-05-12? |
Start
Value |
End
Value |
||||
|---|---|---|---|---|---|---|
| ABBV × |
$10,000.00
2012-12-10 |
$89,839.57
2025-05-12 |
||||
| AbbVie Inc NYSE Common Stock | ||||||
| Year | ABBV |
|---|---|
| 2025 (YTD) | +30.07% |
| 2024 | +18.87% |
| 2023 | −0.23% |
| 2022 | +24.01% |
| 2021 | +32.43% |
| 2020 | +27.72% |
| 2019 | +1.47% |
| 2018 | −0.96% |
| 2017 | +60.08% |
| 2016 | +9.79% |
| 2015 | −6.50% |
| 2014 | +27.92% |
| 2013 | +60.77% |
| 2012 | −2.40% |
| Mon 2012-12-10? to Mon 2025-05-12? |
Final
Drawdown |
Worst
Drawdown |
||||
|---|---|---|---|---|---|---|
| ABBV × | −11.46% |
−45.09%
2019-08-15 |
||||
| AbbVie Inc NYSE Common Stock | ||||||